WO2005123108A3 - Composition a base de vitamine c elaboree presentant une biotransformation amelioree et utilisation de proteines et de l-carnitine pour complementation nutritionnelle ou analogue - Google Patents

Composition a base de vitamine c elaboree presentant une biotransformation amelioree et utilisation de proteines et de l-carnitine pour complementation nutritionnelle ou analogue Download PDF

Info

Publication number
WO2005123108A3
WO2005123108A3 PCT/US2005/020421 US2005020421W WO2005123108A3 WO 2005123108 A3 WO2005123108 A3 WO 2005123108A3 US 2005020421 W US2005020421 W US 2005020421W WO 2005123108 A3 WO2005123108 A3 WO 2005123108A3
Authority
WO
WIPO (PCT)
Prior art keywords
vitamins
advanced
nutritional supplements
protein based
milligrams
Prior art date
Application number
PCT/US2005/020421
Other languages
English (en)
Other versions
WO2005123108A2 (fr
Inventor
William Feinstein
Original Assignee
William Feinstein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Feinstein filed Critical William Feinstein
Priority to CA002514687A priority Critical patent/CA2514687A1/fr
Publication of WO2005123108A2 publication Critical patent/WO2005123108A2/fr
Publication of WO2005123108A3 publication Critical patent/WO2005123108A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28—Substances of animal origin, e.g. gelatin or collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne un complément nutritionnel et une méthode de traitement faisant appel à ce dernier, ce complément comprenant de la vitamine C en quantité généralement comprise entre 250 milligrammes et 5000 milligrammes, en mélange avec de la L-carnitine en quantité généralement comprise entre 100 milligrammes et 5000 milligrammes, et/ou une ou plusieurs protéines qui renferment des acides aminés essentiels et dont la quantité est généralement comprise entre 1 gramme et 150 grammes.
PCT/US2005/020421 2004-06-09 2005-06-09 Composition a base de vitamine c elaboree presentant une biotransformation amelioree et utilisation de proteines et de l-carnitine pour complementation nutritionnelle ou analogue WO2005123108A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002514687A CA2514687A1 (fr) 2004-06-09 2005-06-09 Composition de pointe a base de vitamine c possedant des capacites ameliorees de biotransformation et utilisation de proteines et de l-carnitine comme additifs nutritionnels ou comme substances de meme nature

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57876504P 2004-06-09 2004-06-09
US60/578,765 2004-06-09

Publications (2)

Publication Number Publication Date
WO2005123108A2 WO2005123108A2 (fr) 2005-12-29
WO2005123108A3 true WO2005123108A3 (fr) 2006-05-04

Family

ID=35478562

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/020421 WO2005123108A2 (fr) 2004-06-09 2005-06-09 Composition a base de vitamine c elaboree presentant une biotransformation amelioree et utilisation de proteines et de l-carnitine pour complementation nutritionnelle ou analogue

Country Status (2)

Country Link
CA (1) CA2514687A1 (fr)
WO (1) WO2005123108A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2665742B1 (fr) 2011-01-20 2016-04-20 Oneday - Biotech And Pharma Ltd. Composés antioxydants, anti-inflammatoires, antirayons, chélateurs métalliques et leurs utilisations
EP2694051B1 (fr) * 2011-04-05 2022-10-26 Lonza Ltd Utilisation de l-carnitine et sels de celle-ci pour réduire ou prévenir la fatigue et améliorer la fonction cognitive
EP2508179A1 (fr) * 2011-04-05 2012-10-10 Lonza Ltd. Utilisation de carnitine L, sels et dérivés associés pour réduire ou empêcher la fatigue et améliorer la fonction cognitive
CN104717970A (zh) 2012-07-23 2015-06-17 万德-生物技术及制药有限公司 提高谷胱甘肽的组合物及其用途
EP2877194A4 (fr) 2012-07-25 2016-03-16 Oneday Biotech And Pharma Ltd Compositions et méthodes permettant d'augmenter le niveau de carnitine dans les tissus musculaires
EP2948003B1 (fr) 2013-01-23 2020-03-18 Bottled Science Limited Composition de boisson améliorant la peau
CN103404572B (zh) * 2013-08-22 2015-04-22 北京康比特体育科技股份有限公司 一种能量补充及缓解疲劳的烘焙棒及其制备方法
SE542106C2 (en) 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
JP2018064492A (ja) * 2016-10-18 2018-04-26 株式会社明治 たんぱく質効率向上用の組成物
US10610544B2 (en) 2017-11-03 2020-04-07 Lysulin, Inc. Insulin resistance and beta cell function using lysine-based supplements
US10653720B2 (en) 2017-11-03 2020-05-19 Lysulin, Inc. Prevention of protein glycation using lysine/zinc supplements
US10656166B2 (en) 2017-11-03 2020-05-19 Lysulin, Inc. Inhibiting chronic blood and nephrological disorders using lysine-based supplements
US11255838B2 (en) 2017-11-03 2022-02-22 Lysulin, Inc. Levels, functions, and resistances related to chronic conditions by using lysine-based supplements
CN111990574A (zh) * 2020-09-18 2020-11-27 内蒙古精晶生物科技有限公司 一种左旋肉碱营养泡腾片

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WERBACH M.R.: "Nutritional strategies for treating chronic fatigue syndrome", ALTERNATIVE MEDICINE REVIEW, vol. 5, no. 2, 2000, pages 93 - 108, XP002996198 *

Also Published As

Publication number Publication date
CA2514687A1 (fr) 2005-12-09
WO2005123108A2 (fr) 2005-12-29

Similar Documents

Publication Publication Date Title
WO2005123108A3 (fr) Composition a base de vitamine c elaboree presentant une biotransformation amelioree et utilisation de proteines et de l-carnitine pour complementation nutritionnelle ou analogue
WO2004052295A3 (fr) Compositions et methodes de supplementation nutritionnelle
BR9711278A (pt) FÄrmula nutricional para pacientes com fenilcetonÚria
WO2001028356A3 (fr) Complement alimentaire destine a augmenter la masse maigre et la resistance de celle-ci
CA2467805A1 (fr) Complexes de chrome (iii) et d'acides alpha-amines
PL1898724T3 (pl) Preparat odżywczy dla niemowląt z hydrolizowanymi białkami
EP2705849A3 (fr) Préparation pour utiliser de l'aspartate afin de réguler des taux de glucose dans le sang
AU2003228660A1 (en) Nutritional supplement and method of delivery
WO2001091772A3 (fr) Compositions et procedes pour traiter une gene oculaire
EP1330957A3 (fr) Supplement nutritive
HK1085927A1 (en) The use of lupin conglutin for the preparation of a medicament, food supplements or foods for the treatment of type ii diabetes
EP1300084A3 (fr) Composition pour le traitement des insuffisances veineuses chroniques a l'aide d'un extrait de feuilles de vigne rouge
WO2001091769A3 (fr) Compositions et methodes permettant d'accroitre des effets therapeutiques
WO2003049687A3 (fr) Compositions medicinales et methodes therapeutiques
WO2006134135A3 (fr) Methode nutritionnelle
IL191005A0 (en) Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
WO2002089741A3 (fr) Compositions et methodes permettant d'ameliorer l'administration de medicament
HUP0301568A3 (en) Double offumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
WO2001089315A3 (fr) Methode visant a ameliorer la croissance, la consommation de liquide et l'indice de conversion des aliments chez les oiseaux
CA2285490A1 (fr) Composition pour ameliorer la nutrition des cellules et la capacite energetique des mitochondries
WO2001091766A3 (fr) Compositions et procedes destines a traiter les incommodites de la main et du poignet
WO1999037167A3 (fr) Procede pour ameliorer la stabilite de la vitamine d dans un produit nutritionnel contenant une proteine hydrolysee, et produit obtenu par ce procede
AU5366699A (en) Food supplements comprising lipoic acid and creatine and methods for their use
AU2003253510A1 (en) Arginine/lysine-enriched peptides
WO2008066715A3 (fr) Procédé de traitement utilisant une protéase d'aspergillus oryzae

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2005726396

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2514687

Country of ref document: CA

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWW Wipo information: withdrawn in national office

Ref document number: 2005726396

Country of ref document: EP

122 Ep: pct application non-entry in european phase